Company Overview and News

 
CEA / China Eastern Airlines Corp. Ltd. null

5h sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')[email protected]*, T*)25%3T8-"B @(" @(" @#0HR M,B P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X-"],(#8X+TQE;F=T M:" V,B]3(#,X/CYS=')E86T-"FC>[email protected][email protected]

 
New Strong Sell Stocks for May 17th

2018-05-17 zacks
Accuray Incorporated (ARAY - Free Report) is designer and developer of radiosurgery and radiation therapy systems. The Zacks Consensus Estimate for its current year earnings has been revised 52.6% downward over the last 60 days.

 
Chinese professor curses, threatens to slap airline staff after missing her flight

2018-05-17 newsinfo.inquirer.net
A middle-aged Chinese woman was found swearing at an airline staff in Zhongchuan Lanzhou Airport in Gansu province after she missed her flight.

 
CEA / China Eastern Airlines Corp. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-05-16 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
Air France-KLM hopes 3 CEOs can end its crisis

2018-05-15 money.cnn
Air France-KLM (AFLYY) said Tuesday that it was bringing together the trio as a stopgap measure after the shock resignation of group CEO Jean-Marc Janaillac this month. It continues to look for a permanent replacement.

 
China to ease 'one route, one airline' policy for Chinese carriers

2018-05-14 channelnewsasia
SHANGHAI: China will ease its near decade-old "one route, one airline" policy, the country's aviation regulator said on Monday, opening the door to greater levels of competition on long-haul routes between the nation's state-backed and private carriers.

 
One of Europe's top airlines is in crisis

2018-05-07 money.cnn
Shares in Air France-KLM (AFLYY) crashed as much as 14.5% on Monday after the group's CEO quit over a pay dispute and the French government said it would not intervene to help.

 
CEA / China Eastern Airlines Corp. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-05-07 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
CEA / China Eastern Airlines Corp. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-05-07 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
The future of flight: Higher fares on the way

2018-04-27 nzherald.co.nz
Airfares for business travellers crept up steadily during the past year and are forecast to climb again this year, shows a report done for the travel industry.

 
CEA / China Eastern Airlines Corp. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-27 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
CEA / China Eastern Airlines Corp. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-27 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
CEA / China Eastern Airlines Corp. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-27 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
CEA / China Eastern Airlines Corp. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-27 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 
CEA / China Eastern Airlines Corp. Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-04-27 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 16937R104